Stockhead on MSN2d
Island completes dosing in phase 2b arm of mosquito-borne dengue trialIsland Pharmaceuticals has completed subject dosing for the phase 2b therapeutic arm of its phase 2a/b PROTECT clinical trial ...
GlobalData on MSN2d
AbViro launches NIH-funded dengue challenge trialThe trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.
A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback